HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02557854 |
|
Recruitment Status :
Withdrawn
(Lack of enrollment)
First Posted : September 23, 2015
Last Update Posted : March 19, 2019
|
Sponsor:
Theodore Laetsch
Information provided by (Responsible Party):
Theodore Laetsch, University of Texas Southwestern Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Actual Primary Completion Date : | March 16, 2019 |
| Actual Study Completion Date : | March 16, 2019 |